What is AZN's current stock price?

As of now, AZN is trading at $189.20, with a daily change of +2.57%.

What are the risks associated with AZN stock?

AZN has Low, risk level based on volatility, sector strength, volume, investor confidence and outlook.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

AZN Stock Analysis & IQ Rating | Astrazeneca

AZN AZN Badge

Astrazeneca

$189.20

+$4.75 | +2.57%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$192.79

MKT CAP

$593.75B

52W Low

$61.24

VOL

$2.38M

P/E Ratio

62.85

AVG VOL

$7.35M

RSI

89.73

TREND

Uptrend

AZN Stock IQ

Login to see Astrazeneca (AZN) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

AZN Target Price

Login to display

Not Enough Information

Strengths

AZN Rewards

Earnings are forecast to grow

AZN Rewards

Upgraded on attractively valued

AZN Rewards

Outperform the market

AZN Price Performance

$91.22 (+107.41%)

$81.35 (+132.58%)

$81.22 (+132.95%)

$74.8 (+152.94%)

1year

6month

3month

1month

AZN Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

AZN Analysts Opinion

AZN Analysts opinion is negative but has improved from the past 3 months

AZN Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

79%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

0%

100%

AZN Street Sentiment

AZN Street Sentiment is extremely bullish and have negative views on the near-term outlook

AZN Risk Level

AZN has Low risk level

Risks Indicators

Investors losing confidence

Low

LOW

HIGH

AZN Performance Sentiment

Sentiments overview associated with events and the stock performance

79%

18%

Positive

Negative

22 out of 28
events present

5 out of 28
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support
Price

$92.77

Resistance
Price

$89.94

Current Price Range

$96.34

Show methods +

Analyst Consensus

Recent Upgrades and Downgrades

100%

Buy

Hold

Sell

Consensus Rating

STRONG BUY

7

0

Date

Action

Rating

Firm

Jan 29, 2026

Initiate

Buy

Citigroup

Dec 06, 2025

Reiterate

Overweight

JP Morgan

Nov 12, 2025

Reiterate

Buy

Jefferies

Nov 12, 2025

Reiterate

Overweight

JP Morgan

Nov 08, 2025

Reiterate

Buy

Shore Capital

Linked to AZN

Close Price

Change

PFE

Pfizer

26.72

+3.89%

MRK

Merck Company

119.80

+3.34%

NVS

Novartis AG

153.50

+2.46%

HCM

HUTCHMED (China) Limited

14.78

+2.71%

TEVA

Teva Pharma

35.03

-3.37%

Recently Viewed

Close Price

Change

AZN

Astrazeneca

189.20

+2.57%

EYE

National Vision Holdings

26.97

-1.41%

AAON

92.89

-0.52%

COIN

Coinbase Global

166.70

-7.26%

AOUT

American Outdoor Bra

9.78

+3.93%

AZN Latest Analysis +

AstraZeneca PLC - Depositary Receipt (AZN) Price Target Increased by 107.33% to 202.76. The average one-year price target for AstraZeneca PLC - Depositary Receipt (NasdaqGS:AZN) has been revised to $202.76 / share. This is an increase of 107.33% from the prior estimate of $97.79 dated January 13 2026. The price target is an average of many targe

Today

$189.98 | +3.00%

Potential

FDA Rejects AZNs Saphnelo SubQ Formulation Priority Tag to Datroway. AstraZeneca wins FDA priority review for Datroway in triple-negative breast cancer while Saphnelo SC receives a complete response letter.

Today

$189.98 | +3.00%

Activity

AstraZeneca Stock Soared 103% Monday Holding At High Level. Gets Rating Upgrade.. AstraZeneca saw its IBD SmartSelect Composite Rating rise to 96 Tuesday up from 92 the day before. The post AstraZeneca Stock Soared 103% Monday Holding At High Level. Gets Rating Upgrade. appeared first on Investor'.s Business Daily.

Tue Feb 3, 2026

$184.32 | -2.17%

Rating

Jim Cramer Says I Like AstraZeneca Very Much. AstraZeneca PLC (NASDAQ:AZN) is one of the stocks Jim Cramer shed light on recently. When a caller mentioned that they are thinking of selling their position in the stock for profit and buying ABBV shares Cramer remarked: I like AstraZeneca very much. And that cancer franchise turned out to be a lot stronger than I [….]

Tue Feb 3, 2026

$184.32 | -2.17%

Earnings

AstraZeneca denied FDA approval for subcutaneous version of lupus drug.

Tue Feb 3, 2026

$184.32 | -2.17%

Activity

AstraZeneca Responds With Data After FDA Delays Lupus Drug Shot. The US Food and Drug Administration (FDA) on Tuesday issued a complete response letter (CRL) regarding ) Biologics License Application (BLA) for Saphnelo (anifrolumab) for subcutaneous administration for .AstraZeneca subsequently provided the information requested in the CRL.A decision from the FDA on the updated application for Saphnelo SC is expected in the first half of 2026. Intravenous (IV) Saphnelo remains commercially availa

Tue Feb 3, 2026

$184.32 | -2.17%

Activity

AstraZeneca PLC (NASDAQ:AZN) Announces Strategic Collaboration Agreement With CSPC Pharmaceuticals.

Tue Feb 3, 2026

$184.32 | -2.17%

Activity

AstraZeneca stock falls after FDA rejects lupus drug injection form.

Tue Feb 3, 2026

$184.32 | -2.17%

Momentum

AZN Obesity Pipeline to Get a Boost From Deal With Chinas CSPC. AstraZeneca deepens its obesity push with an eight-program deal with Chinas CSPC securing rights to a once-monthly injectable weight-management pipeline.

Mon Feb 2, 2026

$188.41 | +0.70%

Activity

Potential

AstraZeneca To Invest $15 Bln In China To Advance Medicines Manufacturing And R&D . (RTTNews) - AstraZeneca PLC (AZN) Thursday announced announced $15 billion investment in China through 2030 to expand medicines manufacturing and R&D leveraging the countrys scientific excellence advanced manufacturing and China-UK healthcare ecosystem collaborations.

Thu Jan 29, 2026

$92.59 | -0.68%

Activity

FAQ About AZN Stock Insights

What is AZN current stock price?

What are AZN stock strengths?

What is AZN Risk Level?

What is AZN market cap and volume?

What is AZN current Stock IQ?

Should I buy AZN stock right now?

Is AZN a Strong Buy right now?

What does a 'Strong Buy' rating mean for AZN?

What does a 'Strong Sell' rating mean for AZN?

What factors influence AZN's Stock IQ?

Explore our AZN Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored AZN Stock Strategies
Effective Risk Management

FIND US ON

Receive our AZN Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

AZN AZN Badge

Astrazeneca

Set Alerts

Current Price

$189.20

+$4.75 | +2.57%

52W High

$192.79

MKT CAP

$593.75B

52W Low

$61.24

VOL

$2.38M

P/E Ratio

62.85

AVG VOL

$7.35M

RSI

89.73

TREND

Uptrend

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Linked to AZN

Symbol

Close

Change

PFE

Pfizer

26.72

+3.89%

MRK

Merck Company

119.80

+3.34%

NVS

Novartis AG

153.50

+2.46%

HCM

HUTCHMED (China) Limited

14.78

+2.71%

TEVA

Teva Pharma

35.03

-3.37%

AZN Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

79%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

0%

100%

AZN Street Sentiment

AZN Street Sentiment is extremely bullish and have negative views on the near-term outlook

AZN Risk Level

AZN has Low risk level

Risks Indicators

Investors losing confidence

Low

LOW

HIGH

AZN Performance Sentiment

Sentiments overview associated with events and the stock performance.

79%

18%

Positive

Negative

22 out of 28
events present

5 out of 28
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support
Price

$92.77

Resistance
Price

$89.94

Current Price Range

$96.34

Show methods +

Latest Analyst Actions

Overall Wall Street Rating

100%

Buy

Hold

Sell

Consensus Rating

STRONG BUY

7

0

Date

Action

Rating

Firm

Jan 29, 2026

Initiate

Buy

Citigroup

Dec 06, 2025

Reiterate

Overweight

JP Morgan

Nov 12, 2025

Reiterate

Buy

Jefferies

Nov 12, 2025

Reiterate

Overweight

JP Morgan

Nov 08, 2025

Reiterate

Buy

Shore Capital

AZN Stock IQ

Login to unlock Astrazeneca (AZN) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Target Price

Login to display

Stock Insights

Strengths

AZN Rewards

Earnings are forecast to grow

AZN Rewards

Upgraded on attractively valued

AZN Rewards

Outperform the market

AZN Latest Analysis

AstraZeneca PLC - Depositary Receipt (AZN) Price Target Increased by 107.33% to 202.76. The average one-year price target for AstraZeneca PLC - Depositary Receipt (NasdaqGS:AZN) has been revised to $202.76 / share. This is an increase of 107.33% from the prior estimate of $97.79 dated January 13 2026. The price target is an average of many targe

Today

$189.98 | +3.00%

Potential

FDA Rejects AZNs Saphnelo SubQ Formulation Priority Tag to Datroway. AstraZeneca wins FDA priority review for Datroway in triple-negative breast cancer while Saphnelo SC receives a complete response letter.

Today

$189.98 | +3.00%

Activity

AstraZeneca Stock Soared 103% Monday Holding At High Level. Gets Rating Upgrade.. AstraZeneca saw its IBD SmartSelect Composite Rating rise to 96 Tuesday up from 92 the day before. The post AstraZeneca Stock Soared 103% Monday Holding At High Level. Gets Rating Upgrade. appeared first on Investor'.s Business Daily.

Tue Feb 3, 2026

$184.32 | -2.17%

Rating

Jim Cramer Says I Like AstraZeneca Very Much. AstraZeneca PLC (NASDAQ:AZN) is one of the stocks Jim Cramer shed light on recently. When a caller mentioned that they are thinking of selling their position in the stock for profit and buying ABBV shares Cramer remarked: I like AstraZeneca very much. And that cancer franchise turned out to be a lot stronger than I [….]

Tue Feb 3, 2026

$184.32 | -2.17%

Earnings

AstraZeneca denied FDA approval for subcutaneous version of lupus drug.

Tue Feb 3, 2026

$184.32 | -2.17%

Activity

AstraZeneca Responds With Data After FDA Delays Lupus Drug Shot. The US Food and Drug Administration (FDA) on Tuesday issued a complete response letter (CRL) regarding ) Biologics License Application (BLA) for Saphnelo (anifrolumab) for subcutaneous administration for .AstraZeneca subsequently provided the information requested in the CRL.A decision from the FDA on the updated application for Saphnelo SC is expected in the first half of 2026. Intravenous (IV) Saphnelo remains commercially availa

Tue Feb 3, 2026

$184.32 | -2.17%

Activity

AstraZeneca PLC (NASDAQ:AZN) Announces Strategic Collaboration Agreement With CSPC Pharmaceuticals.

Tue Feb 3, 2026

$184.32 | -2.17%

Activity

AstraZeneca stock falls after FDA rejects lupus drug injection form.

Tue Feb 3, 2026

$184.32 | -2.17%

Momentum

AZN Obesity Pipeline to Get a Boost From Deal With Chinas CSPC. AstraZeneca deepens its obesity push with an eight-program deal with Chinas CSPC securing rights to a once-monthly injectable weight-management pipeline.

Mon Feb 2, 2026

$188.41 | +0.70%

Activity

Potential

AstraZeneca To Invest $15 Bln In China To Advance Medicines Manufacturing And R&D . (RTTNews) - AstraZeneca PLC (AZN) Thursday announced announced $15 billion investment in China through 2030 to expand medicines manufacturing and R&D leveraging the countrys scientific excellence advanced manufacturing and China-UK healthcare ecosystem collaborations.

Thu Jan 29, 2026

$92.59 | -0.68%

Activity

Discover AZN Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of AZN. We're here to help you make informed investment decisions today.

FIND US ON

Receive our AZN Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

AZN Stock trends

AZN Stock performance

AZN Stock analysis

AZN investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing AZN

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing AZN

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

AZN Stock Analysis & IQ Rating | Astrazeneca

AZN Stock IQ

AZN Target Price

AZN Analysts Opinion

AZN Street Sentiment

AZN Risk Level

AZN Performance Sentiment

Key Price Levels

Analyst Consensus

Explore our AZN Stock insights

Receive our AZN Daily Alerts

AZN Street Sentiment

AZN Risk Level

Key Price Levels

Latest Analyst Actions

Discover AZN Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of AZN. We're here to help you make informed investment decisions today.

Receive our AZN Daily Alerts

AZN Alerts